Understanding the Patient Experience with Genetic Testing for Ataxias
The goal of this study is to understand the experience of going through genetic testing for Ataxia by surveying a national registry of patients.
Link to Survey: https://forms.office.com/r/P1YA0RpFS1
About the Study
Eligible Ataxia Types
All Ataxias for which genetic testing was considered or performed.
Type of Study
Survey
Clinical Trial Phase
N/A
Age Range
Children and Adults
Study Start Date
07/01/2024
Estimated Completion Date
06/30/2025
IRB Approval #
HUM00256051
Location(s)
Virtual Study
Contact Information
Sharan Srinivasan
sharans@med.umich.edu
734-615-8116
What does participation in the study entail?
Completion of a one-time survey. This survey only asks about age, sex, and a final diagnosis (if found). No other identifying information is requested.
What are the potential benefits for participants?
Participants may use this survey to better reflect on their own experiences so that we providers may improve the overall flow for future patients.
What are the potential risks for participants?
There is no predicted risk for participants as no intervention is being performed.
Is there financial compensation?
No.
Is there travel reimbursement?
No. Not applicable.
Who is eligible?
All patients, including children and adults over 18 years are eligible to participate as long as genetic testing was at least considered, and/or performed, as part of the diagnostic workup.
Additional Information or Resources
Link to Complete Survey: https://forms.office.com/r/P1YA0RpFS1
View Other Research Opportunities
To Test or Not to Test: Exploring Predictive Genetic Testing Decision Making in Individuals with a Family History of Hereditary Ataxia
Our research goal is to further explore the factors influencing participants’ predictive genetic testing decision-making for hereditary ataxia. We will achieve this by interviewing participants who declined genetic testing as Read More…
Monogenic and Polygenic Risk Prediction for Individuals
MyOme Inc. is a health technology company focused on using genetic testing to help people understand their health risks before problems start. In this study, MyOme is testing a new Read More…
Safety, Empowerment, and Dignity: Improving the Airport Journey of Customers Using Wheelchairs
InterVISTAS is currently collaborating with Indiana University – Bloomington (IUB) to collect information on the air travel experiences of people with disabilities. This project strives to identify ways to enhance Read More…
